cladribine has been researched along with T-Cell Lymphoma in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gurram, V; Kaliyaperumal, M; Kreitman, RJ; Lakshman, MK; Martínez Montemayor, MM; Pottabathini, N; Relangi, SS; Satishkumar, S; Sharma, S; Vuram, PK; Yang, L; Zhou, H | 1 |
| Bányai, A; Gopcsa, L; Karádi, A; Matolcsy, A; Pálóczi, K; Tamáska, J | 1 |
| Al-Toma, A; Goerres, MS; Kerckhaert, JA; Meijer, JW; Mulder, CJ; von Blomberg, BM; Wahab, PJ | 1 |
| Cellier, C; Cerf-Bensussan, N | 1 |
| Bauer, F; Beham-Schmid, C; Brezinschek, R; Jaeger, G; Mannhalter, C; Neumeister, P | 1 |
| Alberto, P; Anchisi, S; Dietrich, PY; Zulian, GB | 1 |
| Hoffman, MA | 1 |
| Lin, WC; Mann, KP; Moore, JO; Smith, C; Traweek, ST | 1 |
| Beutler, E; Carrera, CJ; Carson, DA; Curd, JG; Lotz, M; Piro, LD; Terai, C | 1 |
2 review(s) available for cladribine and T-Cell Lymphoma
| Article | Year |
|---|---|
Cladribine for the treatment of indolent non-Hodgkin's lymphomas.
Topics: Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Humans; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Waldenstrom Macroglobulinemia | 1996 |
Post transplant CD8+ gammadelta T-cell lymphoma associated with human herpes virus-6 infection.
Topics: Antigens, CD; Antineoplastic Agents; Bone Marrow; CD8 Antigens; CD8-Positive T-Lymphocytes; Cladribine; Glomerulonephritis, IGA; Herpesviridae Infections; Herpesvirus 6, Human; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lymphoma, T-Cell; Male; Middle Aged; Postoperative Complications; Receptors, Antigen, T-Cell, gamma-delta | 1999 |
1 trial(s) available for cladribine and T-Cell Lymphoma
| Article | Year |
|---|---|
Cladribine therapy in refractory celiac disease with aberrant T cells.
Topics: Aged; Celiac Disease; Cladribine; Disease Progression; Female; Genes, T-Cell Receptor gamma; Humans; Immunophenotyping; Immunosuppressive Agents; Lymphocyte Depletion; Lymphoma, T-Cell; Male; Middle Aged; Prospective Studies; T-Lymphocytes | 2006 |
6 other study(ies) available for cladribine and T-Cell Lymphoma
| Article | Year |
|---|---|
Cladribine Analogues via O⁶-(Benzotriazolyl) Derivatives of Guanine Nucleosides.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cladribine; Guanosine; Humans; Inhibitory Concentration 50; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Lymphoma, T-Cell; Organophosphorus Compounds; Primary Cell Culture; Structure-Activity Relationship | 2015 |
Hepatosplenic gamma delta T-cell lymphoma with leukemic phase successfully treated with 2-chlorodeoxyadenosine.
Topics: Adult; Antineoplastic Agents; Cladribine; Female; Hepatomegaly; Humans; Lymphoma, T-Cell; Receptors, Antigen, T-Cell, gamma-delta; Recurrence; Remission Induction; Splenomegaly | 2002 |
Treatment of clonal refractory celiac disease or cryptic intraepithelial lymphoma: A long road from bench to bedside.
Topics: Celiac Disease; Cladribine; Disease Progression; Humans; Immunosuppressive Agents; Interleukin-15; Lymphoma, T-Cell | 2006 |
Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine.
Topics: Adult; Alemtuzumab; Anemia, Hemolytic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blood Transfusion; Cladribine; Cyclophosphamide; Doxorubicin; Female; Humans; Liver Neoplasms; Lymphoma, T-Cell; Neutropenia; Prednisolone; Receptors, Antigen, T-Cell, gamma-delta; Recurrence; Remission Induction; Rituximab; Splenic Neoplasms; Vincristine | 2008 |
Cladribine and tumour lysis syndrome.
Topics: Adult; Cladribine; Humans; Lymphoma, T-Cell; Male; Tumor Lysis Syndrome | 1995 |
Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy.
Topics: 2-Chloroadenosine; Adenosine Triphosphate; Cell Survival; Cells, Cultured; Cladribine; Deoxyadenosines; DNA Damage; Humans; Interleukin-6; Lymphoma, T-Cell; Monocytes; Mutagens; NAD; Phagocytosis; Protein Biosynthesis; RNA; Time Factors | 1990 |